Hajime Yoshimura

Hajime Yoshimura

Auto-generated profile, based on publicly available information

Hajime Yoshimura

Department of Neurology, Kobe City Medical Center General Hospital, Japan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
JIJunko Ishii
Junko Ishii
NYNobuhiro Yuki
Nobuhiro Yuki
MKMichi Kawamoto
Michi Kawamoto
HYHajime Yoshimura
Hajime Yoshimura
SKSusumu Kusunoki
Susumu Kusunoki
NKNobuo Kohara
Nobuo Kohara

1 February 2019 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
JOJunichiro Ohira
Junichiro Ohira
HYHajime Yoshimura
Hajime Yoshimura
TMTakeshi Morimoto
Takeshi Morimoto
KAKoichi Ariyoshi
Koichi Ariyoshi
NKNobuo Kohara
Nobuo Kohara

26 July 2022 in Neurology
Verified
Journal Article
Closed access
PDF file
HYHajime Yoshimura
Hajime Yoshimura
Tomotaka TanakaTomotaka Tanaka
Tomotaka Tanaka
KFKazuki Fukuma
Kazuki Fukuma
SMSoichiro Matsubara
Soichiro Matsubara
RMRie Motoyama
Rie Motoyama
TIthe PROPOSE Study Investigators
the PROPOSE Study Investigators
Background and Objectives: The functional outcome and mortality of post-stroke epilepsy (PSE) patients have not been assessed in a prospective study. Previous reports have suggested that PSE patients may suffer from prolonged functional deterioration following a seizure. In the current study, we prospectively investigated the functional outcome and mortality of PSE patients and analyzed the impact of seizure recurrence on the outcomes. Methods: This is part of the Prognosis of Post-Stroke Epilepsy (PROPOSE) study, a multicenter, prospective observational cohort study, where 392 PSE patients (at least one unprovoked seizure more than 7 days after the onset of the last symptomatic stroke) were followed for at least 1 year at eight hospitals in Japan. The current study included only PSE patients with a first-ever seizure and assessed their functional decline and mortality at 1 year. Functional decline was defined as an increase in modified Rankin Scale (mRS) score at 1 year compared to baseline, excluding death. The associations between seizure recurrence and the outcomes were analyzed statistically. Results: A total of 211 patients (median age of 75 years; median mRS score of 3) were identified. At 1 year, 50 patients (23.7%) experienced seizure recurrence. Regarding outcomes, 25 patients (11.8%) demonstrated functional decline, and 20 (9.5%) had died. Most patients died of pneumonia or cardiac disease (seven patients each), and no known causes of death were directly related to recurrent seizures. Seizure recurrence was significantly associated with functional decline (odds ratio 2.96 [95% CI 1.25–7.03], P=0.01), even after adjusting for potential confounders (adjusted odds ratio 3.26 [95% CI 1.27–8.36], P=0.01), but not with mortality (odds ratio 0.79 [95% CI 0.18–2.61], P=0.79). Moreover, there was a significant trend where patients with more recurrent seizures were more likely to have functional decline (8.7%, 20.6%, and 28.6% in none, 1, and 2 or more recurrent seizures, respectively; P=0.006). Discussion: One-year functional outcome and mortality of PSE patients were poor. Seizure recurrence was significantly associated with functional outcome, but not with mortality. Further studies are needed to ascertain whether early and adequate anti-seizure treatment can prevent the functional deterioration of PSE patients.

26 November 2022 in Brain Communications
Verified
Journal Article
Open access
PDF file
SASoichiro Abe
Soichiro Abe
Tomotaka TanakaTomotaka Tanaka
Tomotaka Tanaka
KFKazuki Fukuma
Kazuki Fukuma
SMSoichiro Matsubara
Soichiro Matsubara
RMRie Motoyama
Rie Motoyama
TATakuro Arimizu
Takuro Arimizu
Poststroke epilepsy is a major ischaemic/haemorrhagic stroke complication. Seizure recurrence risk estimation and early therapeutic intervention are critical, given the association of poststroke epilepsy with worse functional outcomes, quality of life and greater mortality. Several studies have reported risk factors for seizure recurrence; however, in poststroke epilepsy, the role of EEG in predicting the risk of seizures remains unclear. This multicentre observational study aimed to clarify whether EEG findings constitute a risk factor for seizure recurrence in patients with poststroke epilepsy. Patients with poststroke epilepsy were recruited from the PROgnosis of POst-Stroke Epilepsy study, an observational multicentre cohort study. The enrolled patients with poststroke epilepsy were those admitted at selected hospitals between November 2014 and June 2017. All patients underwent EEG during the interictal period during admission to each hospital and were monitored for seizure recurrence over 1 year. Board-certified neurologists or epileptologists evaluated all EEG findings. We investigated the relationship between EEG findings and seizure recurrence. Among 187 patients with poststroke epilepsy (65 were women with a median age of 75 years) admitted to the lead hospital, 48 (25.7%) had interictal epileptiform discharges on EEG. During the follow-up period (median, 397 days; interquartile range, 337–450 days), interictal epileptiform discharges were positively correlated with seizure recurrence (hazard ratio, 3.82; 95% confidence interval, 2.09–6.97; P < 0.01). The correlation remained significant even after adjusting for age, sex, severity of stroke, type of stroke and generation of antiseizure medications. We detected periodic discharges in 39 patients (20.9%), and spiky/sharp periodic discharges were marginally associated with seizure recurrence (hazard ratio, 1.85; 95% confidence interval, 0.93–3.69; P = 0.08). Analysis of a validation cohort comprising 187 patients with poststroke epilepsy from seven other hospitals corroborated the association between interictal epileptiform discharges and seizure recurrence. We verified that interictal epileptiform discharges are a risk factor for seizure recurrence in patients with poststroke epilepsy. Routine EEG may facilitate the estimation of seizure recurrence risk and the development of therapeutic regimens for poststroke epilepsy.

7 April 2017 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
JUJun Ueda
Jun Ueda
HYHajime Yoshimura
Hajime Yoshimura
KSKeiji Shimizu
Keiji Shimizu
MHMegumu Hino
Megumu Hino
NKNobuo Kohara
Nobuo Kohara

26 September 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
IKIppei Kishimoto
Ippei Kishimoto
SSShogo Shinohara
Shogo Shinohara
TUTetsuhiro Ueda
Tetsuhiro Ueda
STShoichi Tani
Shoichi Tani
HYHajime Yoshimura
Hajime Yoshimura
YIYukihiro Imai
Yukihiro Imai
Orbital apex syndrome is a localized type of orbital cellulitis, where mass lesions occur at the apex of the cranial nerves. Although nasal septal abscess is uncommon, the organism most likely to cause nasal septal abscess is Staphylococcus aureus, and fungal septal abscesses are rare. Here we present an extremely rare and serious case of orbital apex syndrome secondary to fungal nasal septal abscess caused by Scedosporium apiospermum in a patient with uncontrolled diabetes. A 59-year-old man with a 1-month history of headache underwent consultation in an otolaryngological clinic of a general hospital. He was diagnosed with nasal septal abscess and was treated with incisional drainage and 1 month of an antibiotic drip; however, his symptoms persisted. The patient later complained of diplopia due to bilateral abducens nerve palsy, and was then referred to the department of Otolaryngology – Head and Neck Surgery, Kobe City Medical Center General Hospital. The septal lesion was biopsied under general anesthesia, and S. apiospermum was detected using polymerase chain reaction. The patient was treated with an antifungal drug and surgical resection of the lesion was performed. Although the patient survived, he lost his eyesight. This patient represents the second reported case of nasal septal abscess and orbital apex syndrome caused by S. apiospermum. If not treated properly, septal abscess can be life-threatening and cause severe complications, such as ablepsia.